source
- Amgen ends partnership with TScan Therapeutics as Amylyx announces $350 million offeringAmgen announced it is terminating its collaboration with TScan Therapeutics, a Waltham, Massachusetts company focused on T‑cell therapies. The decision ends a partnership that had been aimed at de…
- STAT launches trust-in-science reporter and editor roles to strengthen scientific coverageSTAT reflects on its founding mission of trusted journalism and how the COVID-19 pandemic highlighted the need for reliable science reporting. The outlet notes a broader crisis of trust in science…